News


Resident News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story
Resident News

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story
Resident News

Immunoscape studying immune response to Covid-19

By JLABS

Read full story
Resident News

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story
Resident News

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story
In the media

Op-Ed: Texas Medical Center is an emerging hub of research, innovation

By Robert Maxwell

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur

By Leena Rao

Read full story
Other news

JLABS TMC Company finds Growth in Shrinking Cells

By JLABS

Read full story
Other news

Congratulations to the JLABS @ TMC Company, Corinnova, Inc. for coming in first place in the RESI San Francisco Innovation Challenge at the 2018 JP Morgan Conference

By JLABS

Read full story